| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OR51F2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | FOLR2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | GRINA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | FOXA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | KIF14 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | GCSH | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NYNRIN | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | LYPD1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BET1L | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | RAN | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
